Shuyuan Yeh
Affiliations: | University of Rochester, Rochester, NY |
Area:
Pathology, Molecular Biology, Cell BiologyGoogle:
"Shuyuan Yeh"
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Chen J, Huang CP, Quan C, et al. (2023) The androgen receptor in bladder cancer. Nature Reviews. Urology |
| Chen D, Chou FJ, Chen Y, et al. (2022) Targeting the radiation-induced ARv7-mediated circNHS/miR-512-5p/XRCC5 signaling with Quercetin increases prostate cancer radiosensitivity. Journal of Experimental & Clinical Cancer Research : Cr. 41: 235 |
| Yang Y, Sheng J, Hu S, et al. (2022) Estrogen and G protein-coupled estrogen receptor accelerate the progression of benign prostatic hyperplasia by inducing prostatic fibrosis. Cell Death & Disease. 13: 533 |
| Ding J, Cui XG, Chen HJ, et al. (2022) Targeting circDGKD Intercepts TKI's Effects on Up-Regulation of Estrogen Receptor β and Vasculogenic Mimicry in Renal Cell Carcinoma. Cancers. 14 |
| He M, Yang H, Shi H, et al. (2021) Sunitinib increases the cancer stem cells and vasculogenic mimicry formation via modulating the lncRNA-ECVSR/ERβ/Hif2-α signaling. Cancer Letters |
| Deng G, Wang R, Sun Y, et al. (2021) Targeting androgen receptor (AR) with antiandrogen Enzalutamide increases prostate cancer cell invasion yet decreases bladder cancer cell invasion via differentially altering the AR/circRNA-ARC1/miR-125b-2-3p or miR-4736/PPARγ/MMP-9 signals. Cell Death and Differentiation |
| Lee SO, Ma Z, Yeh CR, et al. (2021) Corrigendum to: 'New therapy targeting differential androgen receptor signaling in prostate cancer stem/progenitor vs. non-stem/progenitor cells'. Journal of Molecular Cell Biology |
| You B, Sun Y, Luo J, et al. (2021) Androgen receptor promotes renal cell carcinoma (RCC) vasculogenic mimicry (VM) via altering TWIST1 nonsense-mediated decay through lncRNA-TANAR. Oncogene |
| Tian H, Chou FJ, Tian J, et al. (2021) ASC-J9® suppresses prostate cancer cell proliferation and invasion via altering the ATF3-PTK2 signaling. Journal of Experimental & Clinical Cancer Research : Cr. 40: 3 |
| Hu YC, Yeh S, Yeh SD, et al. (2020) Correction: Functional domain and motif analyses of androgen receptor coregulator ARA70 and its differential expression in prostate cancer. The Journal of Biological Chemistry. 295: 17382 |